Managing HIV Drug ResistanceFeatures

Fostemsavir, at Last: A New Treatment Option for Extensive HIV Drug Resistance

#6 in TheBodyPro's Top 10 HIV Clinical Developments of 2020

scientists analyzing
sanjeri via iStock
    David Alain Wohl, M.D.

    David Alain Wohl, M.D.

    David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.